Nouveau Life Pharmaceuticals NOUV Stock
Nouveau Life Pharmaceuticals Price Chart
Nouveau Life Pharmaceuticals NOUV Financial and Trading Overview
| Nouveau Life Pharmaceuticals stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0.0001 USD x 0 |
| Ask | 0.0001 USD x 12359560700 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 1.0E-5 - 0.0001 USD |
| Volume | 100K USD |
| Avg. Volume | 112.81K USD |
| Market Cap | 666.1K USD |
| Beta (5Y Monthly) | -73.875 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NOUV Valuation Measures
| Enterprise Value | 146.17K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.892 |
Trading Information
Nouveau Life Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -73.875 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-5 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 7.175E-5 USD |
NOUV Share Statistics
| Avg. Volume (3 month) | 112.81K USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 6.66B |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2007 |
| Most Recent Quarter (mrq) | March 31, 2012 |
| Next Fiscal Year End | June 30, 2008 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.82% |
| Return on Equity (ttm) | -219.52% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -163872 USD |
| Net Income Avi to Common (ttm) | -503315 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.1K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 145.37K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0 |
| Book Value Per Share (mrq) | 0 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21516 USD |
| Levered Free Cash Flow (ttm) | 101.54K USD |
Profile of Nouveau Life Pharmaceuticals
| Country | United States |
| State | CA |
| City | Los Angeles |
| Address | 3580 Wilshire Blvd |
| ZIP | 90010 |
| Phone | 213 235 8554 |
| Website | N/A |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in providing a platform for remote senior care. The company also enables users to monitor patients in real time and access detailed patient information digitally; and its platform is designed to detect emergencies proactively and facilitate non-face-to-face care services. In addition, the company is developing robotic and artificial intelligence (AI)-based healthcare devices and wearables. The company was formerly known as Gondwana Energy, Ltd. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 1998. The company was incorporated in 1998 and is based in Los Angeles, California. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of Seniorgo.ai.
Q&A For Nouveau Life Pharmaceuticals Stock
What is a current NOUV stock price?
Nouveau Life Pharmaceuticals NOUV stock price today per share is 0.0001 USD.
How to purchase Nouveau Life Pharmaceuticals stock?
You can buy NOUV shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nouveau Life Pharmaceuticals?
The stock symbol or ticker of Nouveau Life Pharmaceuticals is NOUV.
Which industry does the Nouveau Life Pharmaceuticals company belong to?
The Nouveau Life Pharmaceuticals industry is Health Information Services.
How many shares does Nouveau Life Pharmaceuticals have in circulation?
The max supply of Nouveau Life Pharmaceuticals shares is 6.66B.
What is Nouveau Life Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Nouveau Life Pharmaceuticals PE Ratio is now.
What was Nouveau Life Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Nouveau Life Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Nouveau Life Pharmaceuticals company belong to?
The Nouveau Life Pharmaceuticals sector is Healthcare.